We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
FMC Submits Rimisoxafen Regulatory Filing for Approval in Brazil
Read MoreHide Full Article
Key Takeaways
FMC filed rimisoxafen for approval in Brazil, its second global regulatory submission for the herbicide.
Rimisoxafen's dual mode of action showed consistent activity against resistant small-seeded broadleaf weeds.
FMC has advanced three novel herbicide active ingredients to regulatory submission in Brazil.
FMC Corporation (FMC - Free Report) has submitted a regulatory dossier for rimisoxafen to Brazilian authorities, marking the second global regulatory submission for the herbicide following its filing with the U.S. Environmental Protection Agency in July 2026. The filing advances FMC’s efforts to develop next-generation crop protection solutions and bring them to major agricultural markets.
Brazil is one of the world’s largest soybean and corn producers, with more than 50 million hectares of soybeans and more than 20 million hectares of corn under cultivation. Growers are increasingly dealing with resistant broadleaf weeds, including Amaranthus hybridus and Amaranthus palmeri, creating demand for newer methods to enhance crop productivity.
The Herbicide Resistance Action Committee classified rimisoxafen under Groups 12 and 32. Being the first dual mode of action herbicide, its field testing has demonstrated consistent activity against small-seeded broadleaf weeds, including those resistant to other herbicides. The product could therefore help growers diversify weed management programs and support resistance management.
Rimisoxafen is the third novel herbicide active ingredient FMC has advanced to regulatory submission in Brazil, following Isoflex and Dodhylex. These product submissions represent FMC’s depth and productivity in the R&D pipeline and are expected to advance as the regulatory process progresses. However, rimisoxafen remains subject to regulatory review and approval and is not currently registered for sale or use in Brazil or any other country.
FMC shares have slumped 72.6% in the past year compared with the industry’s 10% growth in the same period.
Image Source: Zacks Investment Research
FMC’s Zacks Rank & Key Picks
FMC currently carries a Zacks Rank #5 (Strong Sell).
Some better-ranked stocks in the Basic Materials space are Reliance, Inc. (RS - Free Report) , Avient Corporation (AVNT - Free Report) and Kronos Worldwide, Inc. (KRO - Free Report) .
The Zacks Consensus Estimate for RS’ 2026 earnings is pegged at $22.53 per share, indicating a 58% year-over-year increase. RS’ shares have gained 39.4% over the past year.
The Zacks Consensus Estimate for AVNT’s current-year earnings is pinned at $3.2 per share, indicating a 13.5% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 3.4%. AVNT’s shares have gained 25% over the past year.
The Zacks Consensus Estimate for KRO’s 2026 earnings is pegged at 35 cents per share, indicating a rise of 136.5% year over year. Its earnings beat the Zacks Consensus Estimate in two of the trailing four quarters while missing it in the rest, with an average surprise of 34%.
View the Zacks #1 Rank List
Image: Bigstock
FMC Submits Rimisoxafen Regulatory Filing for Approval in Brazil
Key Takeaways
FMC Corporation (FMC - Free Report) has submitted a regulatory dossier for rimisoxafen to Brazilian authorities, marking the second global regulatory submission for the herbicide following its filing with the U.S. Environmental Protection Agency in July 2026. The filing advances FMC’s efforts to develop next-generation crop protection solutions and bring them to major agricultural markets.
Brazil is one of the world’s largest soybean and corn producers, with more than 50 million hectares of soybeans and more than 20 million hectares of corn under cultivation. Growers are increasingly dealing with resistant broadleaf weeds, including Amaranthus hybridus and Amaranthus palmeri, creating demand for newer methods to enhance crop productivity.
The Herbicide Resistance Action Committee classified rimisoxafen under Groups 12 and 32. Being the first dual mode of action herbicide, its field testing has demonstrated consistent activity against small-seeded broadleaf weeds, including those resistant to other herbicides. The product could therefore help growers diversify weed management programs and support resistance management.
Rimisoxafen is the third novel herbicide active ingredient FMC has advanced to regulatory submission in Brazil, following Isoflex and Dodhylex. These product submissions represent FMC’s depth and productivity in the R&D pipeline and are expected to advance as the regulatory process progresses. However, rimisoxafen remains subject to regulatory review and approval and is not currently registered for sale or use in Brazil or any other country.
FMC shares have slumped 72.6% in the past year compared with the industry’s 10% growth in the same period.
Image Source: Zacks Investment Research
FMC’s Zacks Rank & Key Picks
FMC currently carries a Zacks Rank #5 (Strong Sell).
Some better-ranked stocks in the Basic Materials space are Reliance, Inc. (RS - Free Report) , Avient Corporation (AVNT - Free Report) and Kronos Worldwide, Inc. (KRO - Free Report) .
RS, AVNT and KRO carry a Zacks Rank #2 (Buy) each at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for RS’ 2026 earnings is pegged at $22.53 per share, indicating a 58% year-over-year increase. RS’ shares have gained 39.4% over the past year.
The Zacks Consensus Estimate for AVNT’s current-year earnings is pinned at $3.2 per share, indicating a 13.5% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 3.4%. AVNT’s shares have gained 25% over the past year.
The Zacks Consensus Estimate for KRO’s 2026 earnings is pegged at 35 cents per share, indicating a rise of 136.5% year over year. Its earnings beat the Zacks Consensus Estimate in two of the trailing four quarters while missing it in the rest, with an average surprise of 34%.